B, G., F, N., K, H., M, F., T, M., R, E., . . . T, Y. (2026). Histamine N-methyltransferase inhibition as a novel therapeutic strategy for idiopathic hypersomnia. European journal of pharmacology, 1011, 178475. https://doi.org/10.1016/j.ejphar.2025.178475
Chicago Style (17th ed.) CitationB, Girgin, et al. "Histamine N-methyltransferase Inhibition as a Novel Therapeutic Strategy for Idiopathic Hypersomnia." European Journal of Pharmacology 1011 (2026): 178475. https://doi.org/10.1016/j.ejphar.2025.178475.
MLA (9th ed.) CitationB, Girgin, et al. "Histamine N-methyltransferase Inhibition as a Novel Therapeutic Strategy for Idiopathic Hypersomnia." European Journal of Pharmacology, vol. 1011, 2026, p. 178475, https://doi.org/10.1016/j.ejphar.2025.178475.
Warning: These citations may not always be 100% accurate.
